Abiopharma

🔍 Erickson Paula Kristine (Executive)

Company: CONSTELLATION BRANDS, INC. (STZ)

Report Date: 2026-05-01

Detailed Transactions and Holdings:

• Acquired 1,800 shares of Class A Common Stock (Direct)
  Date: 2026-05-01 | Code: M | equity_swap_involved: 0 | shares_owned_after: 1,867.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Sold 506 shares of Class A Common Stock at $152.82 per share (Direct)
  Date: 2026-05-01 | Code: F | equity_swap_involved: 0 | shares_owned_after: 1,361.00 | transaction_form_type: 4
• Sold 1,800 shares of Restricted Stock Units (Derivative)
  Date: 2026-05-01 | Code: M | Exercise: 2026-05-01 | equity_swap_involved: 0 | shares_owned_after: 3,596.00 | transaction_form_type: 4 | Footnotes: F1, F3, F3

Footnotes:

• F1: Each restricted stock unit represents a contingent right to receive one share of Constellation Brands, Inc. Class A Common Stock.
• F2: Includes shares of Constellation Brands, Inc. Class A Common Stock acquired in January 2026 under the Constellation Brands, Inc. 1989 Employee Stock Purchase Plan.
• F3: The restricted stock units vest in three equal annual installments beginning on the date specified. The restricted stock units disposed of in the reported transaction vested on May 1, 2026. Vested shares are delivered to the reporting person net of shares withheld to satisfy taxes.